Cargando…
Pharmacokinetics and Biologic Activity of Apixaban in Healthy Dogs
Thrombosis is common in critically ill dogs and causes considerable morbidity and mortality. The direct factor Xa inhibitor apixaban is safe, efficacious, and convenient in humans. This study aimed to determine the pharmacokinetics (PK), bioactivity, protein binding, and bioavailability of apixaban...
Autores principales: | Herrera, Noelle D., Birschmann, Ingvild, Wolny, Monika, Papich, Mark G., Brooks, Marjory B., Goggs, Robert |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8287028/ https://www.ncbi.nlm.nih.gov/pubmed/34291105 http://dx.doi.org/10.3389/fvets.2021.702821 |
Ejemplares similares
-
Pharmacokinetics and Pharmacodynamics of an Oral Formulation of Apixaban in Horses After Oral and Intravenous Administration
por: Serpa, Priscila B. S., et al.
Publicado: (2018) -
Increased thrombin activatable fibrinolysis inhibitor activity is associated with hypofibrinolysis in dogs with sepsis
por: Sotos, Katherine E., et al.
Publicado: (2023) -
A Novel Microchip Flow Chamber (Total Thrombus Analysis System) to Assess Canine Hemostasis
por: Iwanaga, Tomoko, et al.
Publicado: (2020) -
Biomarker Guided Diagnosis of Septic Peritonitis in Dogs
por: Martiny, Pia, et al.
Publicado: (2019) -
Corrigendum: Biomarker Guided Diagnosis of Septic Peritonitis in Dogs
por: Martiny, Pia, et al.
Publicado: (2020)